The Same Drug Class Costs $25 or $399 — The GLP-1 Price War Has Three Fronts
Lilly's Foundayo costs $25/month with insurance and Novo's new high-dose Wegovy costs $399 self-pay — a 16-fold spread within the same therapeutic category.
The news. The narrative. The timeline.
Bureau: Chicago
Lilly's Foundayo costs $25/month with insurance and Novo's new high-dose Wegovy costs $399 self-pay — a 16-fold spread within the same therapeutic category.
Novo Nordisk's April 15 price cliff landed today — Wegovy's oral 4mg dose jumped from $149 to $199, with $299 waiting after two months.
CDC's measles count hit 1,714 on April 9 and hasn't been updated since — while the Prevention and Public Health Fund faces elimination.
Trump rewrote Title X to fund fertility counseling over contraception, cutting off birth control access for 2.8 million low-income Americans.
The FY27 budget kills the $1.4B Prevention and Public Health Fund — the same money that pays for outbreak response while measles spreads across 30 states.
Loyal's LOY-002 safety package was accepted by FDA in January — if approved, it becomes the first drug ever cleared to extend lifespan in any species.
Researcher Juyoung Lee used synchrotron 3D imaging to chart every nerve in the clitoris — a map that should have existed decades ago and will reshape pelvic surgery.